In the presented ex vivo model, the gut microbiota in NAFLD-HCC promoted expansion of total and effector IL-10+ Tregs, with reduced expansion of CD8+ T cells. The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.